Publications of Soni Savai Pullamsetti
All genres
Journal Article (85)
2020
Journal Article
175, pp. 53 - 65 (2020)
Assaying epigenome functions of PRMTs and their substrates. METHODS
Journal Article
130 (7), pp. 3560 - 3575 (2020)
Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer. JOURNAL OF CLINICAL INVESTIGATION
Journal Article
6 (23), eaaz6105 (2020)
Reprogramming of tumor-associated macrophages by targeting beta-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer. SCIENCE ADVANCES
Journal Article
11 (1), 1185 (2020)
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension. NATURE COMMUNICATIONS
Journal Article
9 (8), 1755 (2020)
Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas. CELLS
Journal Article
80 (20), pp. 4414 - 4425 (2020)
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma. CANCER RESEARCH 2019
Journal Article
Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction. BRITISH JOURNAL OF PHARMACOLOGY (2019)
Journal Article
10, 2130 (2019)
A RASSF1A-HIF1 alpha loop drives Warburg effect in cancer and pulmonary hypertension. NATURE COMMUNICATIONS
Journal Article
597 (4), pp. 1103 - 1119 (2019)
Mechanisms contributing to persistently activated cell phenotypes in pulmonary hypertension. JOURNAL OF PHYSIOLOGY-LONDON
Journal Article
53 (1), 1801887 (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. EUROPEAN RESPIRATORY JOURNAL
Journal Article
10, 2229 (2019)
Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis. NATURE COMMUNICATIONS
Journal Article
9 (4), 2045894019889775 (2019)
Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure. PULMONARY CIRCULATION
Journal Article
10, 2204 (2019)
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension. NATURE COMMUNICATIONS 2018
Journal Article
10 (2), pp. 276 - 293 (2018)
FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis. EMBO MOLECULAR MEDICINE
Journal Article
24 (12), pp. 3339 - 3352 (2018)
Genomic Location of PRMT6-Dependent H3R2 Methylation Is Linked to the Transcriptional Outcome of Associated Genes. CELL REPORTS
Journal Article
197 (2018)
Adipose-Tissue Secretome Induces Bronchial Smooth Muscle Cell Proliferation Via an IL-6/FoxO1 Dependent Mechanism in Offspring of Obese Mice. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Journal Article
116, pp. 57 - 68 (2018)
Long noncoding RNA LISPR1 is required for S1P signaling and endothelial cell function. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Journal Article
13 (11), e0207915 (2018)
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis. PLOS ONE
Journal Article
197 (2018)
Comparison of the Antifibrotic Efficacy of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-Drug Pirfenidone in Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Journal Article
272, pp. 4 - 10 (2018)
Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018. INTERNATIONAL JOURNAL OF CARDIOLOGY